Tuesday, February 27, 2018
Moffitt: FDA Approves Expanded Use of Immunotherapy Treatment for Lung Cancer Patients

The Food and Drug Administration announced the expanded approval of Imfinzi® (durvalumab), an immunotherapy treatment that is now available as a standard-of-care option for patients with stage III non-small cell lung cancer. ..

Read More
Friday, February 23, 2018
UF:For flu detection, just add water

As one of the worst flu seasons in years continues to take its toll, new technology developed by a University of Florida research team comes at an especially timely moment: It’s the first air sampler that can consistently capture the influenza virus, making it up to 100 times more effective than existing samplers.  ..

Read More
Thursday, February 22, 2018
USF: Shoe offers stroke recovery revolution

A professor at the University of South Florida has created a shoe that could revolutionize recovery for stroke survivors. ..

Read More
Wednesday, February 21, 2018
FAU: Intervention helps couples affected by Alzheimers

A first-of-its-kind study using a 10-week in-home intervention to support couples affected by dementia is showing that “practice does make perfect,” both for the caregiver and the care receiver or person with dementia ..

Read More
Thursday, February 15, 2018
UF:Researchers discover method for harvesting ‘green’ sunscreen ingredient

Scientists at the University of Florida College of Pharmacy have identified a new method to harvest a key ingredient responsible for making the product more environmentally friendly.  ..

Read More
Thursday, February 15, 2018
FIU Researchers take fight against cervical cancer abroad

An engineer in the College of Engineering & Computing has pioneered an easy-to-use imaging system for the diagnosis of cervical cancer, which is potentially life changing for many women with little or no access to specialized health care.  ..

Read More
Tuesday, February 13, 2018
Moffitt: FDA Approves Expanded Use of Immunotherapy Treatment for Lung Cancer Patients

The Food and Drug Administration announced the expanded approval of Imfinzi® (durvalumab), an immunotherapy treatment that is now available as a standard-of-care option for patients with stage III non-small cell lung cancer.  ..

Read More
Tuesday, February 06, 2018
UF Health pediatric oncology patients pilot HealthSteps mobile platform

UF Health is the first in the nation to pilot the mobile application, which was created at the Innovation Hub at the University of Florida using UF resources. ..

Read More
Tuesday, February 06, 2018
FAU: Blind cavefish, extreme environments and isomnia

A new study provides important insight into the evolution of sleep and how we might build a brain that does not need to sleep ..

Read More
Thursday, February 01, 2018
Moffitt Researchers Discover New Approach to Stimulate an Immune Response Against Tumor Cells

In an article published in the January issue of Cancer Cell, the researchers describe how a new type of immunotherapy drug targeting the protein TIM-3 works to stimulate the immune system.  ..

Read More